HIV and hepatotropic viruses: Interactions and treatments

International Journal of STD and AIDS

Volumn 8, Issue 12, 1997, Pages 739-745

  McCarron, Brendan ^a   Main, Janice ^b   Thomas, Howard C ^b  

^a RUCHILL HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Hepatitis viruses; HIV; Interferon alpha; Liver transplantation

Indexed keywords

ALPHA INTERFERON; FAMCICLOVIR; HEPATITIS B VACCINE; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DELTA AGENT HEPATITIS; DRUG EFFICACY; HEPATITIS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS G VIRUS; HEPATITIS VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; FLAVIVIRIDAE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS D; HEPATITIS E; HEPATITIS, VIRAL, HUMAN; HIV; HUMANS; LIVER TRANSPLANTATION;

EID: 0030730607     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971919192     Document Type: Review

References (78)

1. Center for Disease Control. Hepatitis A among drug users. MMWR 1988;37:297-305
2. Henning KJ, Bell E, Braun J, Barker ND. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual men and bisexual men. Am J Med 1995;99:132-6
3. Nanwani R, Coswell S, Boag F, Lawrence AG, Coleman JC. Hepatitis A seroprevalence in homosexual and heterosexual men. Genitourin Med 1994;70:325-8
4. Ballesteros J, Dalre R, Gonzalez A, Delromero J. Are homosexual males a risk group for hepatitis A infection in intermediate endemicity area? Epidemiol Infect 1996;117:145-8
5. Hess G, Clemens R, Bienzle U, Schoenfeld C, Schunck B, Bock HL. Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men. J Med Virol 1995;46:40-2
6. Lebovics E, Dworkin B, Heier S, Rosenthal W. The hepatobiliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol 1988;83:1-7
7. Noonan C, Yoffe B, Mansell P, Melnick J, Hollinger F. Extrachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:5698-702
8. Schmitt MP, Gendrault JL, Schweitzer C, et al. Permissivity of primary cultures of human Kupffer cells for HIV-1. Aids Res Hum Retroviruses 1990;6:987-91
9. Steffan AM, Lafon ME, Gendrault JL, et al. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:1582-6
10. Cao YZ, Friedman KA, Huang YX, et al. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol 1990;64:2553-9
11. Seto E, Yen T, Peterlin B, Ou JH. Transactivation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci USA 1988;85:8286-90
12. Twu JS, Chu K, Robinson WS. Hepatitis B X gene activates k-B like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc Natl Acad Sci USA 1989;86:5168-72
13. Foster GR, Ackrill AM, Goldin RD, et al. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double standard RNA. Proc Natl Acad Sci USA 1991;88:2888-92
14. Goldin RD, Fish DE, Hay A, et al. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J Clin Pathol 1990;43:203-5
15. Krogsgaard K, Lindhardt BO, Nielsen JO, et al. The influence of HTL VIII infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 1987;7:37-41
16. Perrillo RP, Regenstein FG, Roodman ST. Chronic hepatitis B in asymptomatic homosexual men with antibody to human immunodeficiency virus. Ann Intern Med 1986;105:382-3
17. Bodsworth N, Donovan B, Nightingale B. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis 1989;160:577-82
18. Carr A, Cooper DA. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on a protease inhibitor. Lancet 1997;349:995-6
19. Eskild A, Magnus P, Petersen G, et al. Hepatitis B antibodies in HIV infected homosexual men are associated with more rapid HIV disease progression. AIDS 1992;6:571-4
20. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991;163:454-9
21. Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 on the development of the hepatitis B virus carrier state. J Infect Dis 1991;163:1138-40
22. McDonald JA, Caruso L, Karayiannis P, et al. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon. Hepatology 1987;7:719-23
23. Brook MG, Chan G, Yap I, et al. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. BMJ 1989;299:652-6
24. Levy P, Marcellin P, Martinot PM, Degott C, Nataf J, Benhaumou JP. Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology 1990;12:570-4
25. Alexander GJM, Brahm J, Fagan E, et al. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987;2:66-9
26. Saracco G, Mazzela G, Rosina F, et al. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 1989;10:336-41
27. DeStefano E, Friedman R, Friedmankien A, et al. Acid-labile human leucocyte interferon in homosexual men with Kaposi's sarcoma. J Infect Dis 1982;146:451-9
28. Joller-Jemelka HI, Joller PW. Antibodies to endogenous interferon alpha in controls and HIV infected persons in different disease states (Abstract ThBP 133) Vth International Conference on AIDS, Montreal, 1989
29. Lau A, Read S, Williams B. Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome. J Clin Invest 1988;82:1415-21
30. Wong DK, Yim C, Naylor CD, et al. Interferon alfa treatment of chronic hepatitis B: randomised trial in a predominantly homosexual male population. Gastroenterology 1995;108: 165-71
31. Krogsgaard K, Bindslev N, Christensen E, et al. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. J Hepatol 1994;21(4):646-55
32. Katlama C, Ingrand D, Loveday C, et al. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral naive patients - a randomised controlled trial with zidovudine monotherapy. J Am Med Assoc 1996;267:118-25
33. 3. N Eng J Med 1995;333:1662-9
34. Doong SL, Tsai CH, Shinazi RF. Inhibition of the replication of hepatitis B virus in vitro by 2′3′-dideoxy-3′thiacytidine related analogues. Proc Natl Acad Sci USA 1991;88:8495-99
35. Tyrrell DLJ, Fischer K, Savani K, Ian W, Jewell L. Treatment of chimpanzees and ducks with lamivudine, 2′-3′-dideoxy-3′thiacytidine results in a rapid suppression of hepadnaviral DNA in sera (abstract). Clin Invest Med 1993; 16(suppl 4):B77
36. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-61
37. Bartholomew MM, Jansen RW, Jeffers LJ, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1996;349:20-2
38. Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during treatment of transplant recipients with lamivudine. Hepatology 1996;24:711-13
39. Marcellin P, Boyer N, Colin JF, et al. Recombinant alpha-interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine. Gut 1993;32(suppl 2): S106
40. Gilson RJC, Hawkins AE, Kelly GK, Gill SK, Weller IV. No effect of zidovudine on hepatitis B virus replication in homosexual men with symptomatic HIV-1 infection. AIDS 1991;5:217-20
41. Moore KH, Raasch RH, Brouwer KL, et al. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease. Antimicrobial Agents Chemother 1995;39:2732-7
42. McKenzie R, Fried MW, Salle R, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995;333:1099-105
43. Cui L, Yoon S, Schinazi R, Sommadossi JP. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluro-1-b-d-arabinofuranosyl)-5-idouracil in human livers. J Clin Invest 1995;95:555-63
44. Main J, Brown JL, Karayiannis P, et al. A double-blind placebo-controlled study to assess the effect of famciclovir in virus replication in patients with chronic hepatitis B virus infection. J Viral Hepatitis 1996;3:211-15
45. Jaiswall SB, Salgia PB, Sepaha AG, Chitnis DS. Hepatitis B vaccine in patients on haemodialysis. Lancet 1995;346:317-18
46. Choudhury SA, Peters VB. Responses to hepatitis B vaccine boosters in human immunodeficiency virus infected children. Paediatr Infect Dis J 1995;14:65-7
47. Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 1988;109:101-5
48. Loke R, Murray-Lyon I, Coleman J, et al. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis. J Med Virol 1990;31:109-11
49. Carne CA, Weller IV, Waite J, et al. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. BMJ 1987;294:866-8
50. Filion LG, Saginur R, Szczerbak N. Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination. J Exp Immunol 1988;71:405-9
51. Pol S, Driss F, Carnot F, et al. Vaccination against hepatitis B virus: an efficient immunotherapy against hepatitis B multiplication. Acad Sci Paris 1993;316:688-91
52. Giovannini M, Tagger A, Ribero ML, et al. Maternal-infant transmission of hepatitis C virus and HIV infections; a possible interaction. Lancet 1990;335:1166
53. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 1994;84:1020-3
54. Telfer PT, Brown D, Devereux H, Lee CA, Dusheiko GM. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophiliac patients. Br J Haematol 1994;88(1994b):397-9
55. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989;97:1559-61
56. Areias J, Lopes I. Influence of HIV infection on hepatitis C in intravenous drug addicts. Hepatology 1992;16(suppl 2, part 2):195A
57. Boyer N, Marcellin P, Degott C, et al. Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux. J Infect Dis 1992;165:723-6
58. Soriano V, Garciasamaniego J, Bravo R, et al. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Clin Inf Dis 1996;23:585-91
59. Vento S, Di Perri G, Cruciani M, Garofano T, Concia E, Bassetti D. Rapid decline of CD4+ cells after IFN-a treatment in HIV-1 infection. Lancet 1993;341:958-9
60. Pesce A, Taillan B, Rosenthal E, et al. Opportunistic infection and CD4 lymphopenia with interferon treatment in HIV-1 infected patients. Lancet 1993;341:1597
61. Soriano V, Garcia-Samaniego J, Bravo R, et al. Efficacy and safety of alpha interferon treatment for chronic hepatitis C in HIV infected patients. J Infect 1995;31:9-13
62. Vento S, Garofano T, Di Perri G, Cruciani M, Concia E, Bassetti D. Zidovudine therapy associated with remission of chronic active hepatitis C in HIV-1 carriers. AIDS 1991;5:776
63. Bernier R, Tremblay M, Tsoukas C, Bergeron MG. Drug sensitivity of human immunodeficiency virus type 1 isolates after ribavirin therapy. J Infect Dis 1997;175:176-8
64. Japour AJ, Lertora JJ, Meeha PM, et al. A phase-1 study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. J Acquir Immunodefic Syndr Hum Retrovirol 1996;13:235-46
65. Krogsgaard K, Kryger P, Aldershville J, et al. Delta infection and suppression of hepatitis B virus replication in chronic HBsAg carriers. Hepatology 1987;7:42-5
66. Govindarajan S, Cassidy WM, Valinluck B, Redeker AG. Interactions of HDV, HBV and HIV chronic B and D infections and in reactivation of chronic D infection. Prog Clin Biol Res 1991;364:207-10
67. Govindarajan S, Valinluck B. Serum hepatitis B virus DNA in chronic hepatitis B and delta infection. Arch Pathol Lab Med 1985;109:398-9
68. Eyster ME, Sanders JC, Battegay M, Di Bisceglie AM. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci 1995;40:1583-8
69. Zannetti AR, Dawson GJ and Study group of hepatitis E. Hepatitis type E in Italy: a seroepidemiological survey. J Med Virol 1994;42:318-20
70. Wang CH, Flehmig B, Moeckli R. Transmission of hepatitis E virus by transfusion? Lancet 1993;341:825-6
71. Montella F, Rezza G, Di Sorra F, Pezzotti P, Rechia O. Association between hepatitis E virus and HIV infection in homosexual men. Lancet 1994;344:1433
72. Medrano FJ, Sanchez QA, Torronteras R, Leal M, Lissen E. Hepatitis E virus and HIV infection in homosexual men. Lancet 1995;345:127
73. Bissuel F, Houhou N, Leport C, Brun-Vezinet F, Vilde JL. Hepatitis E antibodies and HIV status. Lancet 1996;347:1494
74. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996;334:195-6
75. Hadziyannis S, Wages J, Kim JP, et al. Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. J Hepatol 1995;23(suppl 1):78A
76. Stransky J. The discovery of hepatitis G virus. Cas Lek Cesk 1996;135:99-101 (in Czech)
77. Bell H, Simmonds P, Hellum K, et al. Treatment of infection with hepatitis G virus/GBV-C with interferon-alfa (abstract). J Hepatol 1997;26(suppl 1):203
78. Bouscaret F, Samuel D, Simon F, Dedat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis 1994;19:854-9